Anotia
ORPHA:93976Morphological anomalyInfancy, Neonatal
Эпидемиология15
| Тип оценки | Класс распространённости | Среднее (на 100к) | Регион | Квалификация |
|---|---|---|---|---|
| Point prevalence | <1 / 1 000 000 | 0.03 | Specific population | Value and class |
| Prevalence at birth | <1 / 1 000 000 | 0.028 | Europe | Value and class |
| Point prevalence | <1 / 1 000 000 | — | Europe | Class only |
| Prevalence at birth | <1 / 1 000 000 | 0.04 | France | Value and class |
| Point prevalence | <1 / 1 000 000 | — | France | Class only |
| Prevalence at birth | <1 / 1 000 000 | 0.03 | Italy | Value and class |
| Point prevalence | <1 / 1 000 000 | — | Italy | Class only |
| Prevalence at birth | <1 / 1 000 000 | 0.02 | Sweden | Value and class |
| Point prevalence | <1 / 1 000 000 | — | Sweden | Class only |
| Prevalence at birth | <1 / 1 000 000 | 0.02 | United States | Value and class |
| Point prevalence | <1 / 1 000 000 | — | United States | Class only |
| Prevalence at birth | <1 / 1 000 000 | 0.02 | Finland | Value and class |
| Point prevalence | <1 / 1 000 000 | — | Finland | Class only |
| Prevalence at birth | <1 / 1 000 000 | 0.05 | Chile | Value and class |
| Point prevalence | <1 / 1 000 000 | — | Chile | Class only |
Лекарства и терапия
Источник: Open Targets Platform (в реальном времени)
Клинические исследования
Источник: ClinicalTrials.gov (в реальном времени)